Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Depreciation and Depletion: 2017-2025

Historic Depreciation and Depletion for Rockwell Medical (RMTI) over the last 9 years, with Sep 2025 value amounting to $400,000.

  • Rockwell Medical's Depreciation and Depletion changed 0.00% to $400,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 million, marking a year-over-year change of 0.00%. This contributed to the annual value of $1.6 million for FY2024, which is 33.33% up from last year.
  • Rockwell Medical's Depreciation and Depletion amounted to $400,000 in Q3 2025, which was down 0.00% from $400,000 recorded in Q2 2025.
  • In the past 5 years, Rockwell Medical's Depreciation and Depletion ranged from a high of $400,000 in Q3 2023 and a low of $100,000 during Q3 2021.
  • Over the past 3 years, Rockwell Medical's median Depreciation and Depletion value was $400,000 (recorded in 2023), while the average stood at $363,636.
  • Per our database at Business Quant, Rockwell Medical's Depreciation and Depletion crashed by 50.00% in 2021 and then surged by 300.00% in 2023.
  • Rockwell Medical's Depreciation and Depletion (MRQ) stood at $168,000 in 2021, then increased by 19.05% to $200,000 in 2022, then skyrocketed by 100.00% to $400,000 in 2023, then decreased by 0.00% to $400,000 in 2024, then dropped by 0.00% to $400,000 in 2025.
  • Its last three reported values are $400,000 in Q3 2025, $400,000 for Q2 2025, and $400,000 during Q1 2025.